These genes included neuroblastoma-amplified sequence (NBAS), ETS variant transcription factor 6 (ETV6), transmembrane protein 165 (TMEM165), collagen type IV alpha-3-binding protein (C43BP), serine/threonine-protein phosphatase 5 (PPP5), and short-chain specific acyl-CoA dehydrogenase (ACADS) (Figure 5A–E; Table S18). This evidence concerns the gene CERT1 and neuroblastoma.